imiquimod has been researched along with Lymphopenia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Büyükaşık, Y; Elçin, G; Gülseren, D | 1 |
| Corbett, A; Kermode, AG; Reddel, SW; Triplett, J | 1 |
| Griffin, TD; Jan, MM; Laskas, JW | 1 |
| Ohlfest, JR; Xiong, Z | 1 |
4 other study(ies) available for imiquimod and Lymphopenia
| Article | Year |
|---|---|
Severe cytopenia related with the concomitant use of imiquimod and hydroxyurea.
Topics: Adjuvants, Immunologic; Antineoplastic Agents; Humans; Hydroxyurea; Imiquimod; Leukopenia; Lymphopenia; Male; Middle Aged | 2019 |
Warts and all: Fingolimod and unusual HPV-associated lesions.
Topics: Ankle; Antineoplastic Agents; Anus Neoplasms; Carcinoma, Squamous Cell; Cryotherapy; Fingers; Fingolimod Hydrochloride; Foot Dermatoses; Hand Dermatoses; Humans; Imiquimod; Immunosuppressive Agents; Lymphopenia; Multiple Sclerosis, Relapsing-Remitting; Papillomavirus Infections; Warts | 2019 |
Eruptive Kaposi sarcoma: an unusual presentation in an HIV-negative patient.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; CD4 Lymphocyte Count; Cryotherapy; Humans; Imiquimod; Italy; Lymphopenia; Male; Sarcoma, Kaposi; Skin Neoplasms | 2011 |
Topical imiquimod has therapeutic and immunomodulatory effects against intracranial tumors.
Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Brain Neoplasms; CD8-Positive T-Lymphocytes; Cell Proliferation; Dendritic Cells; Female; Glioma; Humans; Imiquimod; Immunologic Factors; Inflammatory Breast Neoplasms; Interferon-gamma; Luciferases; Lymphopenia; Mice; Mice, Inbred C57BL; T-Lymphocytes, Regulatory; Toll-Like Receptor 7; Transplantation, Isogeneic | 2011 |